Video Experimental Relacionado
Updated: Aug 26, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Asociación entre los anticonceptivos orales y el infarto de miocardio. Una revisión es una revisión
JAMA
|June 13, 1977
Resumen
Fumar cigarrillos aumenta significativamente el riesgo de infarto de miocardio en mujeres menores de 50 años, independientemente del uso de anticonceptivos orales. Los anticonceptivos orales pueden presentar un pequeño riesgo, especialmente en usuarios mayores con otros factores predisponentes.
Área de la Ciencia:
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Farmacología Farmacología.
Sus antecedentes:
- Los factores de riesgo de infarto de miocardio (IM) en mujeres premenopáusicas son críticos.
- El uso de anticonceptivos orales (AC) está muy extendido en este grupo demográfico.
Objetivo del estudio:
- Analizar la asociación entre el uso de OC y MI en mujeres menores de 50 años.
- Identificar los principales factores de riesgo que contribuyen al infarto de miocardio en esta población.
Principales métodos:
- Análisis retrospectivo de mujeres menores de 50 años que experimentaron infarto de miocardio.
- Comparación de factores de riesgo, incluido el uso de anticonceptivos orales y el tabaquismo.
Principales resultados:
- Fumar cigarrillos es el principal factor de riesgo para el infarto de miocardio, independientemente del uso de OC.
- El uso de OC es un factor de riesgo identificado, pero su impacto es pequeño sin otras condiciones predisponentes.
- El aumento del riesgo de mortalidad por el uso de OC es comparable al de la enfermedad tromboembólica.
- Los usuarios de OC mayores (>30 años) con factores de riesgo adicionales exhiben tasas de mortalidad por MI sustancialmente más altas.
Conclusiones:
- Dejar de fumar es fundamental para reducir el riesgo de infarto de miocardio en mujeres.
- El uso de OC debe considerarse cuidadosamente en mujeres con otros factores de riesgo cardiovascular, particularmente aquellas mayores de 30 años.
- Se justifica una mayor investigación sobre los efectos sinérgicos de los OC y otros factores de riesgo.
Videos de Conceptos Relacionados
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...